SELLAS amends CEO Stergiou's COC severance to lump sum; revises Burns, Cicic agreements

SELLAS Life Sciences Group, Inc.

CEO Stergiou's change-in-control severance: lump sum of 24 months base salary plus 1.5x target bonus, full equity vesting, 18-month COBRA.
Non-COC severance for CFO Burns and SVP Cicic: 9 months base salary, pro-rata target bonus, up to 9 months COBRA reimbursement.
COC severance for Burns and Cicic: lump sum of 15 months base salary plus target bonus, 18-month COBRA, immediate full equity vesting.
All three agreements were approved by the board on June 24, 2026, after compensation committee review.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.